Developing cost effective new drugs and therapies is a major challenge for life science industry. Drug development involves a number of phases among which the clinical trial phase is the most complex one. It needs planning, execution and monitoring of clinical trials to obtain reliable study data for regulatory submissions. However, in the clinical trial management, one of the major costs owes to the clinical monitoring. Studies have revealed that conducting frequent monitoring visits to investigational sites and 100% source data verification (SDV)through traditional ways don’t always lead to high data quality. This calls for a smarter and better approach for more efficient study data monitoring. A number of monitoring approaches have evolved these days but the centralized monitoring has been proved to be the most effective approach for improving patient safety and data quality in a cost effective manner. Many regulatory bodies, including FDA, encourage the use of centralized monitoring.
HIPAA breaches could cost your organization thousands of dollars, in addition to damaging your reputation and relationship with your patients. Penalties for not complying with HIPAA rules are divided into two categories: Reasonable Cause and Willful Neglect. Fine for a HIPAA breach owing to reasonable cause ranges between $100 and $50,000 per incident and doesn’t include any jail time. However, in case of willful neglect, the fine ranges from$10,000 to $50,000 for each incident and could also lead to criminal charges. Even a small HIPAA violation on the part of a single employee could jeopardize the reputation of the entire organization. Continue reading “Tips to Avoid Common HIPAA Violations”
With the evolution of pharmaceutical industry, the advent of digital tools, processes and platforms has also been prominent. This has dramatically transformed the facet of clinical trials and is making way for new opportunities to improve the trial processes further. However, in this changing scenario, the professionals need to develop new systems and procedures to evaluate new technologies and analyze if these can streamline the trail experiences. Continue reading “Evolution Of Digitalized Pharmaceutical Industry”
A Continuing Education Credit (CEC) or Continuing Education Unit (CEU) refers to a measure used in continuing education programs for helping professionals maintain their license in the profession. Continuing education is mandatory in several fields and is described as participation in different educational programs and activities. Continue reading “Double Up Your Learning Benefits With HRCI And SHRM Approved Webinars”
With the evolution of the pharmaceutical industry, the advent of digital tools, processes, and platforms has also been prominent. This has dramatically transformed the face of clinical trials and is making way for new opportunities to improve the trial processes further. However, in this changing scenario, the professionals need to develop new systems and procedures to evaluate new technologies and analyze if these can streamline the trail experiences. Continue reading “Technology Based Protocol Development in Pharmaceutical Industry”
A recent survey revealed that by 2050 the global population is anticipated to reach 10 billion and digital health market is expected to reach US$206 billion by 2020.This is the era of digital connection and patients are no longer passive healthcare recipients but active value-seeking clients. This simply means that the world is changing and so should the face of healthcare. Continue reading “Digital Clinical Trial Process – The Future is Bright!”
Document management plays a key role in successfully managing life sciences content. A research revealed that one of the biggest challenges faced by life sciences marketers is content overload and the problem is still ongoing. Only 13% of Pharma and biotech marketers and 17% of med tech marketers think they control content properly. Biotech, med tech, and Pharma industries are trying various means and ways to tackle the growing volume of content. But content strategy and objectives are not clear to most of the marketers in the industry. Continue reading “Structuring Life Sciences Content – An Insight”
A recent research by Pew Research Center showed that nearly 72% adults in the United States own a Smartphone. Mobile device is an innovation that has drastically transformed the way info is obtained and used. Mobile phones have become such an important necessity that everyone wishes to own at least one. As a result, e-learning industries are taking huge advantage of this.
Continue reading “Why Mobile Learning?”
Always there has been a lot of buzz about virtual reality and augmented reality. Most of them wonder if they will revolutionize eLearning or will they enhance eLearning. Above all, can we provide cost-effective eLearning with these emerging technologies?